(Q58421503)

5

object named as

S Basili

0 references

author name string

D Ferro

2

0 references

M Saliola

3

0 references

C Quintarelli

4

0 references

F Balsano

European Journal of Clinical Pharmacology

6

0 references

language of work or name

English

0 references

publication date

1992

0 references

published in

0 references

volume

42

0 references

issue

4

0 references

page(s)

379-83

0 references

cites work

In vivo effects of defibrotide on platelet c-AMP and blood prostanoid levels

1 reference

12 December 2020

Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells

1 reference

12 December 2020

Effectiveness of defibrotide for prophylaxis of deep venous thrombosis after general surgery: a double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

12 December 2020

Haemostatic function in myocardial infarction

1 reference

12 December 2020

Prekallikrein and factor VII as prognostic indexes of liver failure

1 reference

12 December 2020

Plasminogen activator inhibitor (PAI-1) in plasma and platelets

1 reference

12 December 2020

Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol

1 reference

12 December 2020

Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2

1 reference

12 December 2020

Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications

1 reference

12 December 2020

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia

1 reference

12 December 2020

Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood

1 reference

12 December 2020

Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis

1 reference

12 December 2020

Sandwich ELISA for t-PA antigen employing a monoclonal antibody

1 reference

12 December 2020

Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells

1 reference

12 December 2020

Pharmacokinetics of defibrotide in healthy volunteers.

1 reference

12 December 2020

Plasminogen activator release during venous stasis and exercise as determined by a new specific assay

1 reference

12 December 2020

Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay

1 reference

12 December 2020

Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis

1 reference

12 December 2020

Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patients

1 reference

12 December 2020

Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological surgery: a double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease

1 reference

12 December 2020

Detection and partial characterization of an inhibitor of plasminogen activator in human platelets

1 reference

12 December 2020

Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells

1 reference

12 December 2020

Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisol

1 reference

12 December 2020

Studies on the release of a plasminogen activator inhibitor by human platelets

1 reference

12 December 2020

Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium

1 reference

12 December 2020

Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration

1 reference

12 December 2020

Evidence for a rapid inhibitor to tissue plasminogen activator in plasma

1 reference

12 December 2020

The effect of various anticoagulant/antiplatelet mixtures on determination of plasminogen activator inhibitor, platelet proteins and hemostasis parameters

1 reference

12 December 2020

Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor

1 reference

12 December 2020

Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors

1 reference

12 December 2020

Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction

1 reference

12 December 2020

Treatment of Raynaud's phenomenon by fibrinolytic enhancement.

1 reference

12 December 2020